• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAUSCH + LOMB STELLARIS ELITE VISION ENHANCEMENT SYSTEM; UNIT, PHACOFRAGMENTATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAUSCH + LOMB STELLARIS ELITE VISION ENHANCEMENT SYSTEM; UNIT, PHACOFRAGMENTATION Back to Search Results
Model Number BL11145
Device Problems Use of Incorrect Control/Treatment Settings (1126); Failure to Cut (2587)
Patient Problems Retinal Detachment (2047); Vitrectomy (2643)
Event Date 08/06/2019
Event Type  Injury  
Manufacturer Narrative
The system was evaluated on site by field service.The stellaris elite passed functional and diagnostic tests with the system performing within specification.Operation above altitudes of 3000 feet above sea level the vitrectomy cut rate performance requirements shall be derated by no more than 20% per 1000 feet.The lower pressure at higher atmosphere reduces the output pressure driving the vit cutter.So the maximum cut rate at 5500¿ is 1250 cpm.The investigation is ongoing.
 
Event Description
The user facility reported the vitrector was not cutting at speeds higher than 1500 cpm.The vitrectomy was discontinued due to continued excessive vitreous traction and no apparent cutting of vitreous.The posterior capsule was broken with vitreous prolapse.Post-op day 1, there were no visible retinal tears.Post-op day 2, the patient reported flashes of light in the right eye.No retinal tears were visible.Post-op 1 week, the patient reported increased flashes and floaters.Inferior and nasal retinal detachment diagnosed on (b)(6) 2019, the macula was still attached.Retinal reattachment surgery was performed on (b)(6) 2019.The macula was attached at the time of surgery and five retinal tears were noted.Additional intervention was pars plana vitrectomy, gas fill, endolaser, face down positioning for a week with limited physical activities.Post-op on (b)(6) 2019, the patient has spectacle corrected vision of 20/25.Retina exam showed attached retina (including the macula) and 48% gas fill remaining in eye.
 
Manufacturer Narrative
A review of the device history record found the system met specifications.The compressor module and fluidics module underwent additional screening when the system was manufactured based on a suspected issue with the cassette vacuum check at higher elevation locations.The associated non-conformance and corrective action are not contributors to the complaint.The lot history, trend analysis, risk analysis and/or directions for use review were considered acceptable, with the product performing within anticipated rates.No further investigation or corrective action is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STELLARIS ELITE VISION ENHANCEMENT SYSTEM
Type of Device
UNIT, PHACOFRAGMENTATION
Manufacturer (Section D)
BAUSCH + LOMB
rochester NY 14609
MDR Report Key9146477
MDR Text Key167340089
Report Number0001920664-2019-00201
Device Sequence Number1
Product Code HQC
Combination Product (y/n)Y
PMA/PMN Number
K170052
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 01/01/2005,09/04/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/02/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberBL11145
Device Catalogue NumberBL11145
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Date Manufacturer Received10/25/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-